About 3D Bio-Printing
The 3D bio-printing is known as additive manufacturing has its developed various innovations in the diverse areas of manufacturing, engineering, medicine and education. It consists of several processes such as pre-bio printing, bio-printing and post-bio printing. The 3D bio-printing market is directly related to the R&D of drugs, scaffolds, and development of medical implants. As a result, the demand for 3D bio-printing is expected to increase in North region due to technological advancements. It has been observed that increase in stem cells and growth of awareness among by the customers in manufacturing market is expected to flourish the global 3D bio-printing market in future. The manufacturers of 3D bio-printing products are expanding their businesses in Asia-Pacific countries as these countries are more prone to medical activities.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 22.3% |
3D Bio-Printing market companies operating in these industries are focusing more on efficient growth, improvement of operational efficiency and productivity, achieving high safety standards, and focusing on maintaining sustainable development. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launches, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global 3D Bio-Printing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
3D Systems Corporation (United States), Aspect Biosystems Ltd (Canada), GeSIM GmbH (Germany), Bio3D Technologies (Germany), Allevi Inc. (United States), Cyfuse Biomedical KK (Japan), Envision TEC GmbH (United States), Organovo Holdings Inc. (United States), 3Dynamic Systems Ltd (United Kingdom), RegenHU SA (Switzerland) and Stratasys Ltd (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are REGEMAT 3D (Spain), CELLINK (Sweden), 3D Bioprinting Solutions (Russia) and Arcam AB (Sweden).
Segmentation Overview
AMA Research has segmented the market of Global 3D Bio-Printing market by Type (Magnetic Levitation, Inkjet Based 3D Bioprinting, Syringe Based 3D Bioprinting and Laser Based 3D Bioprinting), Application (Drug Testing and Development, Regenerative Medicine, Food Testing, Research and Others) and Region.
On the basis of geography, the market of 3D Bio-Printing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material, the sub-segment i.e. Living Cells will boost the 3D Bio-Printing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Component, the sub-segment i.e. 3D Bio printers will boost the 3D Bio-Printing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technological Advancements in 3D Bio-Printing Market. and Increase in Research and Developments Investments by Various Major Players.
Market Growth Drivers:
Increasing Demand of 3D Bio-Printing in Cosmetics Surgeries. and Rising Incidences of Chronic Diseases.
Challenges:
Harmful Emission of Toxic and Carcinogenic Particles from 3D Bio-Printing.
Restraints:
Large Amount of energy is Consumed by 3D Bio-Printing. and Difficulty in Maintaining the Cell in the Environmental Conditions.
Opportunities:
Upsurge Demand for high-Throughput 3D-Bio printed Tissue Models for Drugs and Research. and Reduction in Cost of 3D Bio-Printed Leads to Demand of 3D Bio-Printing Market.
Market Leaders and their expansionary development strategies
In October 2022, 3D Systems acquired of Volumetric Biotechnologies, a Houston-based biotech company. With this acquisition, 3D Bio-Printing Systems plans to establish a world-class research capability in worldwide and expand the Bio-Printing market.
In October 2023, CELLINK, a global leader in bioprinting technologies, is proud to announce a pioneering innovation in the field of regenerative medicine and tissue engineering with the launch of CELLINK Vivoink, the first-ever medical-grade bioink specially designed to support researchers on their clinical translational journey. CELLINK Vivoink is optimized for superior printability, mechanical stability, and cell viability, making it a game-changer in the bioprinting industry., and In April 2019, Biogelx launched a wide product range of synthetic bioinks for variety of 3D printings applications which is beneficial in delivering predictability, great printability, an easy crosslinking method, and viscosity control in one package.
“According to Food and Drug Administration (FDA), it’s denoted that, the right agency to regulate 3D printed organs as its mission “to promote and protect the public health.” explicitly applies to regulation of “cellular and tissue-based products. However, it is yet to decide on appropriate regulations which cover a manufactured organ rather than a human organ”.
Key Target Audience
3D Bio-Printing Manufacturers, 3D Bio-Printing Traders, End-Use Market Participants of Different Segments of 3D Bio-Printing, Government and Research Organizations, Associations and Industrial Bodies, Research and Consulting Firms, R&D Institutions and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.